Additional file 1 of Mesenchymal stem/stromal cell therapy for COVID-19 pneumonia: potential mechanisms, current clinical evidence, and future perspectives

Additional file 1. Table S1. Clinical trials of cell-based therapies for COVID-19 patients registered in clinicaltrials.gov/ . Table S2. Current outcomes of clinical trials of MSCs in COVID-19 treatment.

附加文件1. 补充表S1：注册于clinicaltrials.gov的针对新型冠状病毒肺炎（COVID-19）患者的细胞治疗临床试验。补充表S2：新型冠状病毒肺炎治疗中间充质干细胞（Mesenchymal Stem Cells, MSCs）临床试验的最新研究结果。